|
Market Closed -
Nasdaq
00:00:00 14/11/2026 +03
|
5-day change | 1st Jan Change | ||
| 241.55 USD | +0.49% |
|
+2.89% | +42.09% |
| 11-03 | RBC Raises Price Target on Jazz Pharmaceuticals to $305 From $296, Keeps Outperform Rating | MT |
| 11-03 | Jazz Pharmaceuticals plc, Q3 2026 Earnings Call, Nov 02, 2026 |
| Market Cap | 15.5B 14.05B 13B 11.73B 22.1B 1,462B 22.88B 156B 61.9B 781B 58.19B 56.95B 2,479B | P/E 2026 * |
62.6x | P/E 2027 * | 14.6x |
|---|---|---|---|---|---|
| Enterprise Value | 18.35B 16.63B 15.38B 13.88B 26.15B 1,730B 27.07B 185B 73.26B 924B 68.86B 67.4B 2,934B | EV / Sales 2026 * |
3.82x | EV / Sales 2027 * | 3.27x |
| Free-Float |
96.76% | Yield 2026 * |
-
| Yield 2027 * | - |
| Markets | Quality | ||
|---|---|---|---|
Nasdaq
| JAZZ | Delayed | |
| JAZZ | Real-time | ||
| J7Z | Real-time | ||
| J7Z | Delayed | ||
| J7Z | Real-time | ||
| J7Z | Delayed | ||
| J7Z | End-of-day quote | ||
| 1JAZZ | End-of-day quote | ||
| J7Z | Delayed |
Last Transcript: Jazz Pharmaceuticals plc
| 1 day | +0.49% | ||
| 1 week | +2.89% | ||
| Current month | +11.84% | ||
| 1 month | +12.65% | ||
| 3 months | -1.39% | ||
| 6 months | +5.59% | ||
| Current year | +42.09% |
| 1 week | 235.89 | 249.99 | |
| 1 month | 202.3 | 249.99 | |
| Current year | 156.95 | 266.38 | |
| 1 year | 156.95 | 266.38 | |
| 3 years | 95.49 | 266.38 | |
| 5 years | 95.49 | 266.38 | |
| 10 years | 86.88 | 266.38 |
| Manager | Title | Age | Since |
|---|---|---|---|
Renée Galá
CEO | Chief Executive Officer | 54 | 11/08/2025 |
Philip Johnson
DFI | Director of Finance/CFO | 62 | 01/03/2024 |
Mary Henderson
CTO | Chief Tech/Sci/R&D Officer | 54 | 01/08/2023 |
| Director | Title | Age | Since |
|---|---|---|---|
Bruce Cozadd
CHM | Chairman | 62 | 01/03/2003 |
Seamus Mulligan
BRD | Director/Board Member | 65 | 18/01/2012 |
Rick Winningham
BRD | Director/Board Member | 66 | 01/01/2010 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 11/3/26 A | Sell | Chief Executive Officer | -1,000 | 0.0015% | ||
| 11/2/26 A | Sell | Founder | -6,000 | 0.0092% | ||
| 10/6/26 A | Sell | Chief Executive Officer | -2,000 | 0.0031% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
| +0.49% | +2.89% | +71.23% | +92.62% | 15.5B | ||
| +1.26% | +6.61% | +40.79% | +145.27% | 1,286B | ||
| +0.79% | +3.45% | +45.84% | +92.04% | 688B | ||
| +0.20% | +1.28% | +26.97% | +114.41% | 521B | ||
| -0.44% | +3.69% | +41.45% | +68.91% | 386B | ||
| +0.55% | +0.70% | +59.02% | +45.79% | 364B | ||
| -0.12% | +0.74% | +28.39% | +58.54% | 302B | ||
| +0.37% | +0.37% | +3.33% | +37.27% | 287B | ||
| -0.30% | +1.14% | +38.29% | +70.56% | 252B | ||
| +0.08% | +0.71% | +34.44% | +123.99% | 208B | ||
| Average | +0.29% | +2.16% | +38.97% | +84.94% | 431B | |
| Weighted average by Cap. | +0.54% | +3.25% | +37.82% | +98.95% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 4.81B 4.36B 4.03B 3.64B 6.85B 453B 7.09B 48.4B 19.19B 242B 18.04B 17.66B 769B | 5.07B 4.59B 4.25B 3.83B 7.22B 478B 7.47B 51.01B 20.23B 255B 19.01B 18.61B 810B |
| Net income | 278M 252M 233M 211M 397M 26.25B 411M 2.8B 1.11B 14.02B 1.04B 1.02B 44.52B | 1.13B 1.03B 950M 857M 1.62B 107B 1.67B 11.41B 4.53B 57.09B 4.25B 4.16B 181B |
| Net Debt | 2.85B 2.58B 2.39B 2.15B 4.06B 268B 4.2B 28.65B 11.36B 143B 10.68B 10.45B 455B | 1.05B 955M 883M 797M 1.5B 99.36B 1.55B 10.61B 4.21B 53.07B 3.95B 3.87B 168B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 13/11/26 | $241.55 | +0.49% | 496,703 |
| 12/11/26 | $240.37 | -3.17% | 584,415 |
| 11/11/26 | $248.24 | +1.14% | 592,854 |
| 10/11/26 | $245.43 | +0.77% | 576,714 |
| 09/11/26 | $243.55 | +3.74% | 886,048 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
- Stock Market
- Stocks
- JAZZ Stock
Select your edition
All financial news and data tailored to specific country editions
















